IMV Corporation provided consolidated earnings guidance for the fiscal year ending September 30, 2022. For the period, the company expected net sales of JPY 12,500 million, operating profit of JPY 1,150 million, profit attributable to owners of parent of JPY 900 million and Net income per share of JPY 55.23.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
869 JPY | +1.05% | +9.86% | +66.79% |
04-09 | Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023. | CI |
03-25 | BioVaxys Technology Plans Private Placement; Down 5.9% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.79% | 86.79M | |
+6.01% | 32.05B | |
+30.33% | 9.01B | |
+13.27% | 8.12B | |
+21.38% | 5.51B | |
+14.43% | 3.76B | |
+21.99% | 3.51B | |
+2.43% | 3.41B | |
-21.78% | 3.35B | |
-12.10% | 2.65B |
- Stock Market
- Equities
- 7760 Stock
- News IMV Corporation
- IMV Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2022